Researchers often use antibodies to detect specific molecules or biological markers because they are remarkably precise at ...

A new study led by researchers at Queen’s University Belfast has found significant variability in regulatory approval ...

A light-induced system accelerated antibody–antigen interactions, enabling detection of tiny amounts of CEACAM-5 in blood ...

Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using real-world data, today announced the launch of Breast Cancer and Non-Small Cell Lung ...

A light-induced detection method rapidly measures tiny amounts of the colorectal cancer biomarker CEACAM-5 in blood plasma, ...

North, the University of Cambridge spin-out behind the Aster™ biomarker platform, has secured £3.2 million in new funding to ...

Senticell, Inc. ("Senticell" or the "Company"), a biotechnology company pioneering a new class of liquid biopsy built on red ...

Puma Biotechnology has launched the phase 2 ALISCA-Lung2 trial (PUMA-ALI-4202; NCT07465757) evaluating the investigational ...

Researchers often use antibodies to detect specific molecules or biological markers, as they are remarkably precise at recognizing their targets ...

Colorectal cancer remains one of the deadliest and most frequently diagnosed gastrointestinal malignancies in the world, and clinicians have long struggled with a frustrating gap: the molecular tools ...

Filing seeks approval for a biomarker-directed, all-oral treatment option for patients whose tumors have MET overexpression or amplification, ...

The New Era of Tumor-Agnostic Cancer Therapy / ALK, Allen Chen, BCR ABL, Bence Jones proteins, biomarkers, BRAF, CA 19-9, ...